92.51 -0.01 (-0.01%)
After hours: 4:42PM EST
|Bid||0.00 x 4000|
|Ask||0.00 x 900|
|Day's Range||92.06 - 92.64|
|52 Week Range||78.74 - 96.06|
|PE Ratio (TTM)||N/A|
|Beta (3Y Monthly)||0.91|
|Expense Ratio (net)||0.13%|
Is Teva Pharmaceutical an Attractive Pick This February?Stock price movementsOn February 15, Teva Pharmaceutical (TEVA) closed at $17.98, 4.05% higher than its previous closing price, 23.24% higher than its 52-week low of $14.59, and 30.74% lower
President Donald Trump delivered his highly anticipated State of the Union address Tuesday night. U.S. investors were hoping for a positive update on trade negotiations with China. The ongoing trade war rattled the market in the fourth quarter, and several major U.S. companies have blamed China for earnings and guidance misses.
Humana Inc. reported Wednesday fourth-quarter earnings and revenue that beat expectations, helped by lower inpatient medical utilization, which was partially offset by higher outpatient spending. The health care company's stock was still inactive in premarket trade. Net income was $436 million, or $2.58 a share, compared with $490 million, or $1.29 a share, in the same period a year ago. Excluding non-recurring items, adjusted earnings per share came to $2.65, above the FactSet consensus of $2.53. Revenue rose to $14.17 billion from $13.19 billion, beating the FactSet consensus of $13.94 billion. For 2019, the company expects adjusted EPS of $17.00 to $17.50, compared with the FactSet consensus of $17.48. Humana shares have dropped 8.6% over the past three months, while the SPDR Health Care Select Sector ETF has slipped 0.2% and the S&P 500 has eased 0.6%.
Is Merck an Attractive Buy after Q4 2018 Results?Stock price movementsOn February 1, Merck (MRK) closed at $76.45, 2.67% higher than its previous closing price, 44.71% higher than its 52-week low of $52.83, and 4.66% below its 52-week high of
[Editor's note: This article was previously published in December 2017. It has since been updated and republished to reflect new fund information.] The best exchange-traded funds (ETF) that you should buy will likely be funds that concentrate their holdings in sectors that can beat the broad market indices. As is the case in almost every calendar year, some of the best ETFs will be top funds from the previous year that continue their momentum into the new year, while others will be recent laggards that make a big turnaround. InvestorPlace - Stock Market News, Stock Advice & Trading Tips But picking the best ETFs for an entire year can be challenging, especially because there are always scenarios that play out that no one could have predicted accurately in advance. Therefore, the smart bets for the top ETFs will be a diverse list of funds that combine the best momentum plays based upon what we know now along with some contrarian bets that go against the herd consensus. * 10 High-Yield Monthly Dividend Stocks So, with that backdrop, here are the seven of the best sector funds that can lead the market … ### iShares Edge MSCI USA Momentum Factor (MTUM) Expenses: 0.15%, or $15 annually for every $10,000 invested Momentum will be a major theme of markets and the best way to capture the trend is iShares Edge MSCI USA Momentum Factor (NYSEARCA:MTUM). Although this ETF does not focus on one single sector, it's a great way to gain exposure to momentum stocks that will inevitably come from the leading sectors, without having to identify them yourself. MTUM offers shareholders exposure to momentum in the market by passively tracking the performance of an index of large- and mid-cap stocks with high relative momentum characteristics. For example, top holdings that met this criteria as of this writing were JPMorgan Chase & Co. (NYSE:JPM), Microsoft Corporation (NASDAQ:MSFT), and Bank of America Corp (NYSE:BAC). ### Financial Select Sector SPDR Fund (XLF) Expenses: 0.13% With rising interest rates and a resilient stock market, financial stocks should maintain leadership, which makes ETFs like the Financial Select Sector SPDR Fund (NYSEARCA:XLF) a smart fund to hold. Higher rates generally translate into wider spreads for financial institutions that lend money, and a healthy stock market means higher profits for the big brokerage firms and other large financial companies involved in capital markets. * 10 Smart Money Stocks to Buy for the Rest of the Year XLF, the oldest financial sector ETF, tracks the Financial Select Sector Index, which focuses primarily on large U.S. stocks like Berkshire Hathaway Inc. (NYSE:BRK.A, NYSE:BRK.B), JPM and BAC. ### Energy Select Sector SPDR (XLE) Expenses: 0.13% Although energy was a lagging sector for much of the past few years, signs of life emerged and this momentum has legs to move into 2019, which would benefit top energy ETFs like Energy Select Sector SPDR (NYSEARCA:XLE). XLE tracks the Energy Select Sector Index, which consists of 25 stocks of companies in the oil and gas industries, as well as energy equipment and services. This means shareholders of XLE get a healthy dose of energy sector stocks like Exxon Mobil Corporation (NYSE:XOM), Chevron Corporation (NYSE:CVX) and Schlumberger Limited. (NYSE:SLB). ### PowerShares S&P SmallCap Information Technology (PSCT) Expenses: 0.29% Technology promises to continue as a market leader this year and funds like PowerShares S&P SmallCap Information Technology (NYSEARCA:PSCT) could be smart bets in the tech sector. After a period of small-caps lagging large-caps, the trend started to turn around, which could make PSCT a smart momentum growth bet. PSCT passively tracks the S&P SmallCap 600 Capped Information Technology Index, which is an S&P SmallCap 600 subset that consists of small-cap stocks of companies that provide information technology-related products and services. * 7 Blue-Chip Stocks That Could Lead the Market Higher This means shareholders get exposure to small info-tech names like MKS Instruments, Inc. (NASDAQ:MKSI), Lumentum Holdings Inc (NASDAQ:LITE) and Stamps.com Inc. (NASDAQ:STMP). ### Health Care SPDR (ETF) (XLV) Expenses: 0.13% Health sector ETFs have taken a hit recently, but they have returned to market leadership, which makes now a good time to consider holding funds like the Health Care SPDR (ETF) (NYSEARCA:XLV). The health sector can work as a long-term growth play or a short- to intermediate-term defensive play, which makes health stocks like XLV top holdings Johnson & Johnson (NYSE:JNJ), Pfizer Inc. (NYSE:PFE) and UnitedHealth Group Inc (NYSE:UNH) a good idea to hold in almost any portfolio. XLV has a good balance of health sector stocks, which means it won't be as volatile as some of the health sector ETFs that are more concentrated in sub-sectors of health. This diversification can also serve as added insulation amid health legislation talks in Congress. ### Vanguard Utilities ETF (VPU) Expenses: 0.10% The utilities sector has quietly remained just behind the major market indices for performance the past few years, and it has recently picked up momentum. Combined with their defensive qualities, utilities ETFs look good for 2019. The Vanguard Utilities ETF (NYSEARCA:VPU) passively tracks an index that consists of 75 quality U.S. utilities stocks like NextEra Energy Inc (NYSE:NEE), Duke Energy Corp (NYSE:DUK) and Southern Co (NYSE:SO). * 5 Dividend Stocks to Help You Through the Market's Mayhem The defensive nature of utilities will show its value once the stock market sees another major correction, which remains a real possibility in 2019. ### Consumer Staples Select Sect. SPDR (ETF) (XLP) Expenses: 0.13% Diversification will likely be a major theme in 2019 and a smart move for that purpose is to hold a defensive stock ETF like the Consumer Staples Select Sect. SPDR (ETF) (NYSEARCA:XLP). If stocks continue their climb, this year will see the nine-year anniversary for the bull market, which is getting old by historical standards. Therefore, now is arguably one of the best times in a decade to begin shifting portfolio holdings to a more defensive posture. XLP holds a wide variety of defensive stocks like Procter & Gamble Co (NYSE:PG), Philip Morris International Inc. (NYSE:PM), and The Coca-Cola Co (NYSE:KO). As of this writing, Kent Thune did not personally hold a position in any of the aforementioned securities. However, he holds XLE, XLV and XLP in some client accounts. Under no circumstances does this information represent a recommendation to buy or sell securities. ### More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 5 Machine-Learning Stocks to Buy for a Smarter Portfolio * 10 Stocks to Sell in February * 10 Triple-A Stocks to Buy in February Compare Brokers The post 7 Sector ETFs to Buy for 2019 and Beyond appeared first on InvestorPlace.
Is Pfizer an Attractive Buy after Its Q4 Results?Share price movementsOn January 29, Pfizer (PFE) released its fourth-quarter and fiscal 2018 results. The stock closed at $40.77, which is 3.14% higher than its previous closing price. The company
Is Bristol-Myers Squibb an Attractive Buy after Its Q4 Results?Share price movements On January 25, Bristol-Myers Squibb (BMY) closed at $48.93, which is 0.18% lower than its previous closing price. The company closed at a premium of 10.45% compared
The best way to maximize returns, especially in a year like 2019, is to pick the best sector funds with the potential to beat the broader market indices. While it's not wise to allocate most or all of your investment assets to just one area of the market, adding two or three sectors to a portfolio can have the dual benefit of maximizing return potential while reducing market risk through diversification. Choosing the single best sector that will lead the market in any given year is difficult, to say the least. But choosing three, and having at least two of them outperform, is possible and even prudent, if you choose them consciously and strategically. InvestorPlace - Stock Market News, Stock Advice & Trading Tips For example, I selected the technology, health and energy sectors in 2018. The former two did well and the latter one did not. The result was that the three-way combination boosted the total performance of my model portfolio because my chosen sectors collectively outperformed the S&P 500 index. * 7 Stocks That Could Double in 2019 With that backdrop in mind, here are seven sector funds for you to consider in 2019: ### Best Sector Funds for 2019: Consumer Staples Select Sector SPDR (XLP) Expenses: 0.13% or $13 for every $10,000 invested In a slowing economy, consumers still buy the staples needed for everyday life, which makes sector funds like Consumer Staples Select Sector SPDR (NYSEARCA:XLP) a wise holding for 2019. When stock prices appear to be entering a period of volatility and downside potential, investors like the defensive qualities of consumer staples stocks, such as XLP top holdings, Procter & Gamble Company (NYSE:PG), Coca-Cola Company (NYSE:KO) and PepsiCo Inc (NYSE:PEP). Although consumer staples will typically underperform growth stocks in a healthy economy, they can outperform in a slowing economy, which may be the case in 2019. Source: Shutterstock ### Healthcare Select Sector SPDR (XLV) Expenses: 0.13% A leading sector in 2018, healthcare stocks may have a repeat performance in 2019. To cover healthcare stocks, the Healthcare Select Sector SPDR (NYSEARCA:XLV) is a top choice. The healthcare sector has the distinction of being a smart defensive move, a short-term momentum play and a long-term growth investment, all in one sector. These combined qualities make XLV a go-to sector choice for long-term investors wanting to increase return potential while adding a defensive quality to their portfolio. * 5 of the Best Stocks to Buy and Hold for the Long Term Top holdings in the XLV ETF include Johnson & Johnson (NYSE:JNJ), UnitedHealth Group (NYSE:UNH) and Pfizer Inc (NYSE:PFE). ### Financial Select Sector SPDR (XLF) Expenses: 0.13% A moderately healthy economy combined with slowly rising interest rates can be ripe for financial stocks and sector funds like Financial Select Sector SPDR (NYSEARCA:XLF). Although rising interest rates tend to erode the profitability of many industries, banks can do well in this environment because the spread between their borrowing costs and the rates they charge their customers for loans widens. A volatile stock market will also increase trading activity, which can benefit brokerage firms. Given this economic and market environment in 2019, look for financial stocks to do well, including XLF holdings such as Berkshire Hathaway Inc (NYSE:BRK.B), JPMorgan Chase (NYSE:JPM) and Bank of America (NYSE:BOA). Source: Shutterstock ### SPDR Gold Shares (GLD) Expenses: 0.4% Gold and other precious metals can be a valuable hedge against the real potential for a softer economic outlook than forecast at the beginning of 2019. A highly liquid, low-cost gold fund like SPDR Gold Shares (NYSEARCA:GLD) may shine bright in this environment. The price of gold tends to move higher amidst market volatility, downside pressure on stocks, falling interest rates (or a rate pause when investors expect a rise), a weakening U.S. dollar and geopolitical uncertainty. Although there is no recession in sight, any or all of these conditions are highly possible in 2019, especially in the second half of the year. * 10 Hot Stocks to Buy Right Now GLD does not invest directly in gold, nor does it hold stocks of gold mining companies; it tracks the price of gold via its benchmark, the LBMA Gold Price PM. Source: Shutterstock ### Utilities Select Sector SPDR (XLU) Expenses: 0.13% Continuing on the theme of defensive sector funds, Utilities Select Sector SPDR (NYSEARCA:XLU) is primed to be a top performing ETF in 2019. The utilities sector is considered to be defensive because consumers still need utilities, such as gas, electric, water and phone, no matter what the economy is doing. And since there is no viable, lower-cost alternative to these services, stocks of utilities companies can maintain greater price stability in a weakening, uncertain economic environment. Also, companies and sector funds that pay dividends will compete with bonds as investments, which in 2019 will likely favor XLU and top holdings NextEra Energy (NYSE:NEE), Duke Energy Corporation (NYSE:DUK) and Dominion Energy (NYSE:D). Source: Shutterstock ### iShares Telecommunications (IYZ) Expenses: 0.43% Telecommunications is another defensive sector that can be a smart investment choice for 2019, which makes iShares Telecommunications (BZX:IYZ) among my picks for best sector funds for the year. The qualities of defensive sector funds that investors like include stable earnings and cash flow. To get these qualities, look no further than big U.S. telecommunications and IT stocks like IYZ top holdings, Verizon (NYSE:VZ), AT&T (NYSE:T), and Cisco Systems (NASDAQ:CSCO). * 7 Stupidly Cheap Stocks to Buy Now Like other defensive sectors, such as healthcare and utilities, telecommunications companies tend maintain greater price stability in volatile markets, as 2019 will almost certainly see. Source: Shutterstock ### Global X Robotics & Artificial Intelligence (BOTZ) Expenses: 0.68% Although the technology sector saw big swings in price in 2018, there's still growth potential there, especially in choice sub-sectors, such as artificial intelligence (AI). This makes Global X Robotics & Artificial Intelligence (NYSEARCA:BOTZ) a potential winner for 2019. BOTZ, the largest AI ETF on the market, invests in stocks of companies that may benefit from the increased adaptation of robotics and artificial intelligence technologies. AI expansion looks to continue in 2019 and beyond, which will benefit stocks, such as BOTZ top holdings Intuitive Surgical Inc (NASDAQ:ISRG), Mitsubishi Electric Corp (OTCMKTS:MIELF) and ABB-LTD Reg (NYSE:ABB). As of this writing, Kent Thune did not personally hold a position in any of the aforementioned securities, although he holds XLP, XLV, GLD, and XLU in some client accounts. His No. 1 holding is his privately held investment advisory firm in Hilton Head Island, S.C. Under no circumstances does this information represent a recommendation to buy or sell securities. ### More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Recession-Proof Stocks to Buy ... According to Goldman Sachs * 10 Triple-A Stocks to Buy in February * 7 Smart Money Opinions on Where Stocks Are Going Next Compare Brokers The post 7 of the Best Sector Funds for 2019 appeared first on InvestorPlace.
Analysts Give Positive Ratings to Merck ahead of Q4 ResultsAnalysts’ recommendations and target priceMerck (MRK) is scheduled to post its fourth-quarter and fiscal 2018 results on February 1. In this article, we’ll discuss stock price movements
With lower negative earnings revisions, the healthcare sector is expected to witness earnings growth of 7.7% in the fourth quarter, suggesting continued outperformance for healthcare ETFs.
Analysts Are Mostly Positive on Celgene ahead of Q4 ResultsAnalysts’ recommendations and target priceCelgene (CELG) is expected to post its fourth-quarter and fiscal 2018 results on January 31. In this article, we’ll first take a look at the
Healthcare, the second-largest sector weight in the S&P 500, was the best-performing sector in the U.S. last year and that strength is carrying over to 2019. The Health Care Select Sector SPDR ETF (NYSEArca: ...
Healthcare ETFs weakened Wednesday after Abbot Laboratories (ABT) slipped on a revenue miss and revealed an uninspiring forecast for the first quarter of the new year. The Health Care Select Sector SPDR ETF (XLV) fell 0.3% on Wednesday while the S&P 500 was 0.1% lower. Abbot Laboratories' quarterly revenue fell short of expectations due to lower sales of generic drugs in the emerging markets, Reuters reports.
Johnson & Johnson expects its sales growth to slow down this year due to pricing pressures and generic-drug competition for its pharmaceutical division. This has put healthcare ETFs in focus.
How Johnson & Johnson and Abbott Laboratories Stack Up(Continued from Prior Part)Stock price movements On January 17, Abbott Laboratories (ABT) closed at $70.52. On January 17, Abbott Laboratories’ market capitalization was $123.41 billion.
Johnson & Johnson Releases Its 2018 Results: Revenue Up 6.7%Revenue trends Today, Johnson & Johnson (JNJ) released its fourth-quarter and 2018 financial results. Johnson & Johnson’s net revenue rose ~1% YoY (year-over-year) to $20.4
Becton Dickinson & Co. said it expects to swing to fiscal first-quarter net earnings per share of $2.05, from a loss of 76 cents in the same period a year ago. Excluding non-recurring items, adjusted EPS is expected to rise to $2.70 from $2.48, above the FactSet consensus of $2.59. Revenue is expected to rise 35% to $4.16 billion, topping the FactSet consensus of $4.11 billion. The medical technology company affirmed its 2019 revenue growth outlook of 8.5% to 9.5%, and its adjusted EPS guidance of $12.05 to $12.15. The stock, which was still inactive in premarket trade, has lost 5.6% over the past three months, while the SPDR Health Care Select Sector ETF has declined 5.5% and the S&P 500 has given up 6.9%.
Merck & Co. or AbbVie: Which Is Performing Better This Month? On January 10, AbbVie’s market cap was $132.91 billion. Based on its closing price on January 10, the company had reported returns of 2.21% in the last week, 0.67% in the last month, and -6.74% in the last quarter.
'Halftime Report' guest Mario Gabelli, Gabelli Funds Founder & Chairman, answers viewer questions on financials, health care, autos, and more.
Ron Weiner of RDM Financial Group talks to Yahoo Finance's Julie Hyman and Adam Shapiro about where he sees growth in stocks right now.